Varex Imaging Corp (VREX)
Official siteHEALTHCARE • MEDICAL DEVICES • NASDAQ
Market Cap: $768.59M
Last updated: Nov 17, 2026 at 11:05 AM ET
Varex Imaging Corp (VREX) Financials: Revenue, Profit and Cash Flow
Varex Imaging reported revenue of $844.60M for the fiscal year ended Sep 30, 2025, up 4.1% from the year before. That year, net income was -$69.90M with a net margin of -8.3%, operating cash flow was $41.70M and free cash flow was $18.80M. The quarter ended Jun 30, 2026 had revenue of $210.50M and net income of $15.90M.
Revenue and Margins
The operating margin was -3.3% in the fiscal year ended Sep 2025. Over the 9 years to Sep 2025, revenue grew from $620.10M, a compound annual rate of 3.5%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Sep 2025 | $844.60M | +4.1% | 34.4% | -3.3% | -8.3% |
| Sep 2024 | $811.00M | -9.2% | 31.7% | 4.0% | -6.0% |
| Sep 2023 | $893.40M | +4.0% | 32.5% | 8.6% | 5.4% |
| Sep 2022 | $859.40M | +5.0% | 33.0% | 10.3% | 3.6% |
| Sep 2021 | $818.10M | +10.8% | 33.2% | 9.1% | 2.2% |
| Sep 2020 | $738.30M | -5.4% | 25.8% | -4.6% | -7.8% |
| Sep 2019 | $780.60M | +0.9% | 32.9% | 5.9% | 2.0% |
| Sep 2018 | $773.40M | +10.8% | 32.8% | 5.8% | 3.7% |
| Sep 2017 | $698.10M | +12.6% | 36.3% | 12.0% | 7.4% |
| Sep 2016 | $620.10M | N/A | 40.1% | 17.6% | 11.1% |
Income Statement
In the fiscal year ended Sep 2025, the net loss widened from the year before. In the quarter ended Jun 2026, net income turned positive after a loss in the same quarter a year earlier.
Annual
| Line item | Sep 2025 | Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 | Sep 2019 | Sep 2018 | Sep 2017 | Sep 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $844.60M | $811.00M | $893.40M | $859.40M | $818.10M | $738.30M | $780.60M | $773.40M | $698.10M | $620.10M |
| Cost of revenue | $554.10M | $554.10M | $603.10M | $575.90M | $546.60M | $548.10M | $523.90M | $519.50M | $444.60M | $371.70M |
| Gross profit | $290.50M | $256.90M | $290.30M | $283.50M | $271.50M | $190.20M | $256.70M | $253.90M | $253.50M | $248.40M |
| Research and development | $91.10M | $87.00M | $84.80M | $77.00M | $71.90M | $78.90M | $78.10M | $83.00M | $67.30M | $53.50M |
| Operating income | -$27.80M | $32.10M | $77.10M | $88.20M | $74.10M | -$33.70M | $45.70M | $44.50M | $83.70M | $109.10M |
| Net income | -$69.90M | -$48.30M | $47.90M | $30.80M | $17.90M | -$57.40M | $15.80M | $28.30M | $52.00M | $69.00M |
| EBITDA | -$2.30M | $61.80M | $92.70M | $128.40M | $117.90M | $3.30M | $84.10M | $91.70M | $116.10M | $121.90M |
Quarterly
| Line item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $210.50M | $216.00M | $209.60M | $228.90M | $203.00M | $212.90M | $199.80M | $205.70M | $209.10M | $206.20M | $190.00M | $227.40M |
| Gross profit | $76.70M | $72.60M | $69.80M | $77.80M | $67.50M | $76.70M | $68.50M | $67.10M | $66.90M | $65.80M | $57.10M | $78.00M |
| Operating income | $22.80M | $14.40M | $15.40M | $19.60M | -$80.70M | $22.10M | $11.20M | $10.90M | $9.30M | $7.70M | $4.20M | $24.30M |
| Net income | $15.90M | -$8.00M | $2.40M | $12.20M | -$89.10M | $7.10M | -$100.00K | -$51.00M | $1.50M | $1.60M | -$400.00K | $31.20M |
Balance Sheet
As of Sep 2025, total debt of $367.50M exceeded cash and equivalents by $222.50M.
Annual
| Line item | Sep 2025 | Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 | Sep 2019 | Sep 2018 | Sep 2017 | Sep 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $1.11B | $1.21B | $1.25B | $1.18B | $1.15B | $1.14B | $1.04B | $987.90M | $1.04B | $622.40M |
| Current assets | $641.80M | $649.90M | $658.30M | $609.90M | $554.20M | $522.00M | $438.40M | $458.10M | $495.30M | $359.90M |
| Cash and equivalents | $145.00M | $168.70M | $152.60M | $89.40M | $144.60M | $100.60M | $29.90M | $51.90M | $83.30M | $36.50M |
| Total liabilities | $620.80M | $670.40M | $668.60M | $637.70M | $651.00M | $673.70M | $580.20M | $548.50M | $649.90M | $86.10M |
| Short-term debt | $1.50M | $46.30M | $1.50M | $2.10M | $2.80M | $2.50M | $30.70M | $25.00M | $20.00M | $0 |
| Long-term debt | $366.00M | $397.10M | $441.10M | $412.30M | $431.70M | $452.80M | $364.40M | $364.80M | $463.90M | $0 |
| Shareholder equity | $472.60M | $529.10M | $567.70M | $533.40M | $483.30M | $451.70M | $444.90M | $426.20M | $379.00M | $526.00M |
Quarterly
| Line item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $1.10B | $1.09B | $1.10B | $1.11B | $1.07B | $1.36B | $1.33B | $1.22B | $1.25B | $1.25B | $1.24B | $1.25B |
| Total liabilities | $589.50M | $601.30M | $607.20M | $620.80M | $603.90M | $793.70M | $778.00M | $667.80M | $657.40M | $661.50M | $659.30M | $668.60M |
| Cash and equivalents | $99.20M | $85.30M | $119.50M | $145.00M | $136.40M | $205.10M | $176.00M | $168.70M | $156.40M | $141.80M | $141.30M | $152.60M |
| Shareholder equity | $496.60M | $474.20M | $476.90M | $472.60M | $455.30M | $549.70M | $540.20M | $535.10M | $581.20M | $576.10M | $568.90M | $567.70M |
Cash Flow
In the fiscal year ended Sep 2025, free cash flow was 45.1% of operating cash flow.
Annual
| Line item | Sep 2025 | Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 | Sep 2019 | Sep 2018 | Sep 2017 | Sep 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $41.70M | $47.30M | $108.40M | $16.90M | $92.60M | $13.20M | $71.90M | $85.30M | $75.20M | $74.20M |
| Capital expenditures | $22.90M | $26.90M | $20.70M | $21.30M | $15.10M | $23.50M | $19.80M | $20.40M | $20.20M | $28.90M |
| Free cash flow | $18.80M | $20.40M | $87.70M | -$4.40M | $77.50M | -$10.30M | $52.10M | $64.90M | $55.00M | $45.30M |
| Dividends paid | N/A | N/A | N/A | $2.80M | $1.30M | $53.10M | $500.00K | $600.00K | $227.10M | $0 |
| Investing cash flow | $10.30M | -$27.50M | -$44.90M | -$48.40M | -$16.20M | -$26.90M | -$93.20M | -$25.20M | -$292.00M | -$21.60M |
| Financing cash flow | -$75.90M | -$3.30M | -$200.00K | -$23.80M | -$32.30M | $83.60M | -$100.00K | -$90.40M | $263.30M | -$36.80M |
Quarterly
| Line item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $21.00M | -$1.50M | -$16.10M | $7.90M | $7.70M | $16.60M | $9.50M | $25.90M | $8.00M | $3.10M | $10.30M | $47.10M |
| Capital expenditures | $9.00M | $6.20M | $10.70M | $5.60M | $6.30M | $6.80M | $4.20M | $6.00M | $4.70M | $5.80M | $10.40M | $5.40M |
| Free cash flow | $12.00M | -$7.70M | -$26.80M | $2.30M | $1.40M | $9.80M | $5.30M | $19.90M | $3.30M | -$2.70M | -$100.00K | $41.70M |
Frequently Asked Questions About VREX
What is Varex Imaging's annual revenue?
Varex Imaging reported revenue of $844.60M for the fiscal year ended Sep 30, 2025.
How fast is Varex Imaging's revenue growing?
Revenue was up 4.1% for the fiscal year ended Sep 30, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was -0.6%.
Is Varex Imaging profitable?
No. Varex Imaging reported net income of -$69.90M for the fiscal year ended Sep 30, 2025, with a net margin of -8.3%.
How much free cash flow does VREX generate?
For the fiscal year ended Sep 30, 2025, operating cash flow of $41.70M minus capital expenditures of $22.90M produced free cash flow of $18.80M.
How much debt does Varex Imaging have?
The balance sheet dated Sep 30, 2025 reported long-term debt of $366.00M, short-term debt of $1.50M and cash and equivalents of $145.00M.
VREX pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors, Government Contracts